Ontruzant is a HER2/neu receptor antagonist indicated for: The treatment of HER2-overexpressing breast cancer. ONTRUZANT (trastuzumab-dttb) for injection can be imported for personal use under "patient name basis" treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.
Therapeutic indications and Usage
Ontruzant is a HER2/neu receptor antagonist indicated for: The treatment of HER2-overexpressing breast cancer. The treatment of HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma. Select patients for therapy based on an FDA-approved companion diagnostic for a trastuzumab product
Active ingredient: trastuzumab-dttb
DISEASE INDICATIONS: Breast Cancer
MANUFACTURER : Merck Sharp & Dohme Corp.,
DOSAGE FORM & STRENGTHS: For Injection: 150 mg lyophilized powder in a single-dose vial for reconstitution
MEDICINE APPROVED BY: European Medical Agency (EMA), Food and Drug Administration (FDA)
Source Details: Patient Information
Patient Name Basis Treatment IPN, New Delhi can facilitate patient to import of "ONTRUZANT (trastuzumab-dttb) for injection" in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP).
Healthcare Professional In India
If you have any question, please email IPN Support Team or Call Indian Pharma Network for ONTRUZANT (trastuzumab-dttb) for injection price list or cost in India. on
Mr. Tarun:- +91 9891 296 838
Mr. Neeraj:- +91 9811 747 774
We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.
ONTRUZANT is a prescription medicine. ONTRUZANT is used to treat HER2-overexpressing breast cancer.
Ontruzant is a HER2/neu receptor antagonist indicated for:
• The treatment of HER2-overexpressing breast cancer.
• The treatment of HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.
Select patients for therapy based on an FDA-approved companion diagnostic for a trastuzumab product.
IPN, New Delhi can facilitate patient to import of "ONTRUZANT (trastuzumab-dttb) for injection" in small quantities for personal use. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of ONTRUZANT (trastuzumab-dttb) injection in India, Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the ONTRUZANT (trastuzumab-dttb) injection medicine cost price in India.
The order for ONTRUZANT (trastuzumab-dttb) injection will be confirmed only after
1. submitting Form 12A, along with the prescription of the Registered Medical Practitioner (RMP).
2. Permission from obtained from the office of the Drugs
Controller General (India).
3. Availability of ONTRUZANT (trastuzumab-dttb) from authorised distributor.
Trastuzumab-dttb injection is used to treat HER2-overexpressing node positive or node negative (ER/PR negative or with one high risk feature) breast cancer. It can be used alone after a previous treatment with an anthracycline medicine or with other cancer medicines (eg, carboplatin, cyclophosphamide, docetaxel, doxorubicin, paclitaxel).
ONTRUZANT (trastuzumab-dttb) for injection, for intravenous use Initial U.S. Approval: 2019
For Injection: 150 mg lyophilized powder in a single-dose vial for reconstitution
For ONTRUZANT (trastuzumab-dttb) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Merck Announces US Launch of ONTRUZANT ® (trastuzumab-dttb), a Biosimilar of Herceptin® (trastuzumab) For More Details
Samsung Bioepis Announces Four-year Follow-up Data for Biosimilar ONTRUZANT® (trastuzumab-dttb) in Early or Locally Advanced HER2-positive Breast Cancer For More Details
Step 1. Send a request for your medicine online:-
Applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP).Step 2. Verification of documents:-
We verify your a prescription and necessary documents to import drugs in small quantities for personal use.Step 3. Permission to Import:-
After getting approval of Drugs Controller General (India), we start the process to import of drugs as mentioned in prescription for personal use.Step 4. We source your medicine:-
Our expert sourcing team work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.Step 5. Delivery of medicine:-
After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine. Doctor’s Prescription –
We would require prescription from Registered Medical Practitioner (RMP) stating product name, dosage, duration of treatment and diagnosis.
Patient’s Medical history –
We would require all test reports and medical reports of the patient for last 3 months.
Patient’s Identity card –
We will require scan copy of patient’s identity card and proof of residence to initiate documentation process.
Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. Indian Pharma Network, New Delhi can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.
Send your query to find out -
ONTRUZANT (trastuzumab-dttb) price in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
ONTRUZANT (trastuzumab-dttb) price in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
ONTRUZANT (trastuzumab-dttb) price in North America – Mexico.
ONTRUZANT (trastuzumab-dttb) price in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
ONTRUZANT (trastuzumab-dttb) price in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
ONTRUZANT (trastuzumab-dttb) price in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
ONTRUZANT (trastuzumab-dttb) price in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
ONTRUZANT (trastuzumab-dttb) price in Australia and New Zealand.
Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised cold chain couriers. If you would like your order to be shipped by a specific courier, please inform us when you place the order. Our standard delivery time varies from 5 to 10 working days. The shipping cost depends on the medicine and the destination country. After making an enquiry, you will receive a detailed quote that includes the shipping costs.
